BNP Paribas Financial Markets
CERE

BNP Paribas Financial Markets’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

BNP Paribas Financial Markets’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-61,985
Closed -$1.75M – 4011
2022
Q3 		$1.75M Buy
+61,985
New +$1.75M ﹤0.01% 1500